Resmed AirCurve 11 ASV

AirCurve™ 11 ASV* includes a widely clinically studied adaptive-servo ventilation therapy on the market for patients presenting with central sleep apnea (CSA), obstructive sleep apnea (OSA), mixed apneas and periodic breathing. The ASV* algorithm is designed to use each patient’s unique minute ventilation and respiratory rate to deliver therapy that stabilizes ventilation for more comfortable breathing throughout the night.

* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnea.